Jeffrey S. Weber, MD, PhD
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Pat...
Marianne J. Davies, DNP, ACNP, AOCNP
Julie R. Brahmer, MD, MSc
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
Scott Kopetz, MD, PhD
Prof Eric Van Cutsem, MD, PhD
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
Mark A. Socinski, MD
Helena Yu, MD
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Gilberto de Lima Lopes Junior, MD, MBA, FAMS
Kai He, MD, PhD
Jyoti D. Patel, MD, FASCO
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
Warner K. Huh, MD
Deborah K. Armstrong, MD
Robert L. Coleman, MD, FACOG, FACS
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Perspectives
Suresh S. Ramalingam, MD
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Javier Cortes, MD, PhD
Giuseppe Curigliano, MD, PhD
Peter Schmid, FRCP, MD, PhD
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negative Metastatic Breast Cancer
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negativ...
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients...
Ming-Sound Tsao, MD, FRCPC
How to Approach Liquid Biopsy in the Treatment of NSCLC
D. Ross Camidge, MD, PhD
Luis Paz-Ares, MD, PhD
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
Peter H. O'Donnell, MD
Daniel P. Petrylak, MD
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
Celestia S. Higano, MD
Joaquin Mateo, MD, PhD
Precision Medicine in Advanced Prostate Cancer: A Focus on PARP Inhibitors
Robert Mocharnuk, MD
Alexander Drilon, MD
Because You Care About Your Patients With ROS1+ NSCLC: Recent Revolutions in Treatment
Because You Care About Your Patients With ROS1+ NSCLC: Recent Revolutions in ...
Key Highlights from the Latest Clinical Trials in Lung Cancer
Loading...
Stay current with the best on medical education
Learn More
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
